Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

NCT02579044 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02579044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Lead sponsor
Boston Children's Hospital
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
December 31, 2015
Completion date
March 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progeria